Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeASG SuperconductorsASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf Combine Magnetic Resonance Imaging with Proton Therapy

ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf Combine Magnetic Resonance Imaging with Proton Therapy

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

FDA Will Follow The Science On COVID-19 Vaccines For Young Children

As schools around the country are re-opening for in-person learning and families are returning to their busy school year schedules, we know many parents...

FDA Makes Significant Progress in Science-Based Public Health Application Review, Taking Action on Over 90% of More Than 6.5 Million ‘Deemed’ New Tobacco Products Submitted

As required by statute, a key consideration in their review of premarket tobacco product applications submitted for products like e-cigarettes is to determine whether permitting the marketing of the product would be "appropriate for the protection of the public health," taking into account the risks and benefits to the population as a whole.

NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode

"This represents yet another critical milestone met by the Company as we continue to execute our strategy.  The next steps for the Company are to expand the sEEG labeling for longer term use, which we believe will be a key part of our commercialization strategy for the Evo sEEG electrode, and complete development of an sEEG ablation electrode/probe for ablation of brain tissue and permanently implanted stimulation electrodes for patients with chronic applications such as epilepsy, Parkinson's disease and chronic back pain," said Dave Rosa, CEO of NeuroOne.

April 19, 2021

ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology.

The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting MgB2 magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.

Proton therapy is an emerging radiation technology to irradiate tumors while sparing the surrounding tissue better than conventional X-ray-based radiation due to the finite penetration depth of the protons. However, the effectiveness of proton therapy is limited by tumor motion, anatomical changes during therapy and set-up inaccuracies in patient positioning.

With the new MRI device and its real-time, high-contrast imaging capabilities for organs in the chest, abdomen and pelvis, Aswin Hoffmann from HZDR and his team now intend to build a first prototype which might be used clinically at some stage: “What is special about this MRI scanner is that it can be rotated around the patient relative to the beam, allowing us to study dosimetric and biological beam effects for MRI magnetic fields both perpendicular and parallel to the proton beam.”

ASG Superconductors is now producing a mid-field-strength open 0.5 Tesla MRI device, which is specifically adapted to the requirements of real-time MRI-guided radiation therapy by the Alberta Health Services LINAC-MR group and its spin-off company MagnetTx Oncology Solutions. MagnetTx Oncology Solutions is developing the gantry that is required to rotate the MRI scanner as well as the image processing methods for automatically tracking the tumor in real time. The design and manufacture of the entire 30-ton device is currently in full swing. In summer 2022, the team plans to incorporate it in the actively scanned, clinical-akin experimental proton beamline at the OncoRay facility.

It is very exciting for ASG Superconductors to be part of this project in collaboration with HZDR and MagnetTx,” says Marco Belardinelli ASG Paramed MRI Unit Director and adds, “seeing our MRI and MgB2 superconducting technology used as a key component in new and innovative applications such as this one, which will ultimately benefit the patients and the medical community, makes us proud and even more confident we are moving in the right direction.”

“Our partnership with HZDR and ASG has been extremely positive,” says Mike Cogswell, MagnetTx President and CEO. “We look forward to continuing to work together to improve the cancer treatment industry.”

“Thanks to this collaboration between HZDR and international industrial partners, we are a big step closer to our goal of bringing significant innovation to the field, especially to real-time image-guided proton therapy,” says Hoffmann.

spot_img

DON'T MISS

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Holmes Regional Medical Center Deploys Carestream Systems to Meet a Wide Array of Diagnostic Imaging Needs

Holmes Regional Medical Center opted to outfit their R/F room with the capabilities of a fully functioning digital radiography (DR) room, as well as the standard features of a conventional R/F room, by installing a CARESTREAM DRX-Ascend system with an overhead tube in conjunction with the DRX-Excel Plus.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy